Botulinum toxin for the upper limb after stroke (BoTULS) trial: effect on impairment, activity limitation, and pain

Lisa C. Shaw, Christopher I.M. Price, Frederike van Wijck, Phil Shackley, Nick Steen, Michael P. Barnes, Gary A. Ford, Laura A. Graham, Helen Rodgers

Research output: Contribution to journalArticle

Abstract

Botulinum toxin is increasingly used to treat upper limb spasticity due to stroke, but its impact on arm function is unclear. We evaluated botulinum toxin for upper limb spasticity and function post stroke. Three hundred thirty-three patients with stroke with upper limb spasticity and reduced arm function participated in a multicenter randomized controlled trial. The intervention group received botulinum toxin type A injection(s) plus a 4-week therapy program. The control group received the therapy program alone. Repeat injection(s) and therapy were available at 3, 6, and 9 months. The primary outcome was upper limb function at 1 month (Action Research Arm Test). Secondary outcomes included measures of impairment, activity limitation, and pain at 1, 3, and 12 months. Outcome assessments were blinded and analysis was by intention to treat.

Original languageEnglish
Pages (from-to)1371-1379
Number of pages9
JournalStroke
Volume42
Issue number5
DOIs
Publication statusPublished - Mar 2011

Keywords

  • botulinum toxin
  • stroke
  • randomized controlled trial
  • upper limb
  • spasticity

Fingerprint Dive into the research topics of 'Botulinum toxin for the upper limb after stroke (BoTULS) trial: effect on impairment, activity limitation, and pain'. Together they form a unique fingerprint.

  • Cite this

    Shaw, L. C., Price, C. I. M., van Wijck, F., Shackley, P., Steen, N., Barnes, M. P., Ford, G. A., Graham, L. A., & Rodgers, H. (2011). Botulinum toxin for the upper limb after stroke (BoTULS) trial: effect on impairment, activity limitation, and pain. Stroke, 42(5), 1371-1379. https://doi.org/10.1161/STROKEAHA.110.582197